Title: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
infection after allogeneic stem cell transplantation.
Takashi Onaka1),M.D.,Fumie Iwai1),
Ph.D.,M.D.,Aiko Kato-Ogura1), Ph.D.,M.D. Akihito
Yonezawa1), Ph.D.,M.D.
1)Department of Hematology, Kokura Memorial Hospital,Japan
Corresponding author: Takashi Onaka,M.D.
3-2-1,Asano,Kokura-kita,Kitakyushu,Fukuoka,Japan
Tel +81-93-511-2000Fax +81-93-511-2259
e-mail:takashionaka3@gmail.com
Key Clinical Massege: This is the first report of a case of COVID-19
after allogeneic stem cell transplantation. Our case suggests that
COVID-19 may exist without characteristic CT images, especially in
immunocompromised hosts, such as patients after transplantation.
Key words:COVID-19,Allogeneic transplantation,malignant lymphoma
Introduction:
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the
novel coronavirus first detected in Wuhan, China.The virus causes
coronavirus disease 2019 (COVID-19).Over 1000000 cases of COVID-19 have
been confirmed worldwide.1Here, we report the first
case of COVID-19 after allogeneic stem cell transplantation.
Case Examination:
A 61-year-old male with diffuse large B cell lymphoma transformed from
follicular lymphoma underwent peripheral blood stem cell transplantation
(PBSCT) from his HLA haploidentical daughter. He underwent de-escalation
of immunosuppressant drugs because of early relapse after PBSCT. The
duration of chronic graft-versus-host disease(GVHD) was extended, but he
did not need additional therapy. At day 205 after PBSCT, he had a fever
of 100°F and a wet cough. He visited our hospital because his symptoms
persisted for two days. He had not traveled to a foreign country nor had
contact with anyone with COVID-19. His chest X-ray showed no apparent
bacterial pneumonia, and a CT scan showed only small nodules that were
diagnosed as scar tissue from past organizing pneumonia and pleural
effusion (figure 1). Although he was radiographically atypical for
COVID-19,a COVID-19 PCR test was performed on a nasopharyngeal swab.
Laboratory tests showed leukopenia (WBC 1000/μl),neutropenia (ANC 20/μl)
, a high procalcitonin level (8.94 ng/ml), and a high CRP level (26.3
mg/dl). He was hospitalized and started taking antibiotics with a
diagnosis of community-acquired pneumonia.PCR was positive the day after
hospitalization.By the ninth day in the hospital, his respiratory
condition had not worsened.
Discussion:
Currently, COVID-19 is spreading around the world. It has been reported
that there are typical COVID-19 imaging patterns on chest CT. Chinese
researchers revealed bilateral lung opacities on chest CT in COVID-19
patients and described lobular and subsegmental areas of consolidation
as the most typical findings.2 Another study found
that the hallmarks of COVID-19 on imaging were bilateral and peripheral
ground-glass and consolidative pulmonary
opacities.3However, in our patient, we did not find
typical findings on CT. This is the first report of a case of COVID-19
after allogeneic stem cell transplantation. Absence of the
characteristic imaging features might be related to leukopenia or
immunosuppression. Our case suggests that COVID-19 may exist without
characteristic CT images, especially in immunocompromised hosts, such as
patients after transplantation.
Conclusion:
Although there are many unclear points about COVID19, there may not have
shown typical images, and it is important to note the possibility of
infection, especially in immunocompromised patients.
Authorship
TO: managed the patient and wrote the manuscript.
FI,AO,and AY: reviewed the manuscript.
Conflict of interest
None declared.
Figure legend
1-A) Chest CT findings. Organizing pneumonia was observed in both upper
lobes.
1-B) Chest CT findings.Bilateral pleural effusion was present.
References
1. World Health Organization. Novel coronavirus — China. January12,
2020
(http://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/.
opens in new tab).
2.Huang C, Wang Y, Li X et al.Clinical features of patients infected
with 2019 novel coronavirus in Wuhan, China. Lancet2 020 January
24 (Epub ahead of print), doi: 10.1016/S0140-6736(20)30183-5.